Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
ADPT — Adaptive Biotechnologies Corporation
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025
REVENUE
$94.0M +59.6%
NET MARGIN
10.2% +53.7 PTS
EPS
$0.06 +136.8%
FREE CASH FLOW
-$7.5M +42.4%

No summary has been written for this call yet.